{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:20:50Z","timestamp":1792686050763,"version":"4.5.0"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA151993"],"award-info":[{"award-number":["R01 CA151993"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35 CA197735"],"award-info":[{"award-number":["R35 CA197735"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 CA230873"],"award-info":[{"award-number":["R21 CA230873"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA248857"],"award-info":[{"award-number":["R01 CA248857"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R50 CA274122"],"award-info":[{"award-number":["R50 CA274122"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"crossref","award":["C10674\/A27140"],"award-info":[{"award-number":["C10674\/A27140"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["CRP-24-1185864-01-PROF"],"award-info":[{"award-number":["CRP-24-1185864-01-PROF"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001299","name":"Prevent Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001299","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005292","name":"Brigham and Women's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000969","name":"American Institute for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008548","name":"Harvard T.H. Chan School of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008548","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10654-025-01322-w","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:21:06Z","timestamp":1761567666000},"page":"1405-1417","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The early-onset cancer epidemics: evidence synthesis using the prospective cohort incident-tumor biobank method"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3909-2323","authenticated-orcid":false,"given":"Shuji","family":"Ogino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Ugai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomotaka","family":"Ugai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"issue":"10","key":"1322_CR1","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41571-022-00672-8","volume":"19","author":"T Ugai","year":"2022","unstructured":"Ugai T, Sasamoto N, Lee H, et al. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat Rev Clin Oncol. 2022;19(10):656\u201373. https:\/\/doi.org\/10.1038\/s41571-022-00672-8.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1322_CR2","doi-asserted-by":"publisher","first-page":"e000049","DOI":"10.1136\/bmjonc-2023-000049","volume":"2","author":"J Zhao","year":"2023","unstructured":"Zhao J, Xu L, Sun J, et al. Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019. BMJ Oncol. 2023;2(1):e000049. https:\/\/doi.org\/10.1136\/bmjonc-2023-000049.","journal-title":"BMJ Oncol"},{"issue":"1","key":"1322_CR3","doi-asserted-by":"publisher","first-page":"pkaf002","DOI":"10.1093\/jncics\/pkaf002","volume":"9","author":"BA Weinberg","year":"2025","unstructured":"Weinberg BA, Murphy CC, Freyer DR, et al. Rethinking the rise of early onset gastrointestinal cancers: a call to action. JNCI Cancer Spectr. 2025;9(1):pkaf002. https:\/\/doi.org\/10.1093\/jncics\/pkaf002.","journal-title":"JNCI Cancer Spectr"},{"issue":"1","key":"1322_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1470-2045(24)00600-4","volume":"26","author":"H Sung","year":"2025","unstructured":"Sung H, Siegel RL, Laversanne M, et al. Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data. Lancet Oncol. 2025;26(1):51\u201363. https:\/\/doi.org\/10.1016\/S1470-2045(24)00600-4.","journal-title":"Lancet Oncol"},{"issue":"12","key":"1322_CR5","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.annonc.2024.08.2336","volume":"35","author":"S Ogino","year":"2024","unstructured":"Ogino S, Ugai T. The global epidemic of early-onset cancer: nature, nurture, or both? Ann Oncol. 2024;35(12):1071\u20133. https:\/\/doi.org\/10.1016\/j.annonc.2024.08.2336.","journal-title":"Ann Oncol"},{"issue":"1","key":"1322_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41575-023-00841-9","volume":"21","author":"CC Murphy","year":"2024","unstructured":"Murphy CC, Zaki TA. Changing epidemiology of colorectal cancer\u2014birth cohort effects and emerging risk factors. Nat Rev Gastroenterol Hepatol. 2024;21(1):25\u201334. https:\/\/doi.org\/10.1038\/s41575-023-00841-9.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"1322_CR7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.cgh.2023.11.040","volume":"22","author":"S Gupta","year":"2024","unstructured":"Gupta S, May FP, Kupfer SS, Murphy CC. Birth cohort colorectal cancer (CRC): implications for research and practice. Clin Gastroenterol Hepatol. 2024;22(3):455-69.e7. https:\/\/doi.org\/10.1016\/j.cgh.2023.11.040.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"1322_CR8","doi-asserted-by":"publisher","first-page":"e583","DOI":"10.1016\/S2468-2667(24)00156-7","volume":"9","author":"H Sung","year":"2024","unstructured":"Sung H, Jiang C, Bandi P, et al. Differences in cancer rates among adults born between 1920 and 1990 in the USA: an analysis of population-based cancer registry data. Lancet Public Health. 2024;9(8):e583\u201393. https:\/\/doi.org\/10.1016\/S2468-2667(24)00156-7.","journal-title":"Lancet Public Health"},{"key":"1322_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaf050","author":"L Owens","year":"2025","unstructured":"Owens L, Fung A, Shuhendler J, et al. Trends in young-onset cancer incidence: a modeling perspective. JNCI J Natl Cancer Inst. 2025. https:\/\/doi.org\/10.1093\/jnci\/djaf050.","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"5","key":"1322_CR10","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.cell.2012.04.023","volume":"149","author":"S Nik-Zainal","year":"2012","unstructured":"Nik-Zainal S, Van Loo P, Wedge DC, et al. The life history of 21 breast cancers. Cell. 2012;149(5):994\u20131007. https:\/\/doi.org\/10.1016\/j.cell.2012.04.023.","journal-title":"Cell"},{"issue":"2","key":"1322_CR11","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1073\/pnas.1914589117","volume":"117","author":"K Lahouel","year":"2020","unstructured":"Lahouel K, Younes L, Danilova L, et al. Revisiting the tumorigenesis timeline with a data-driven generative model. Proc Natl Acad Sci USA. 2020;117(2):857\u201364. https:\/\/doi.org\/10.1073\/pnas.1914589117.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1322_CR12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/emph\/eoae021","volume":"12","author":"F Thomas","year":"2024","unstructured":"Thomas F, DeGregori J, Marusyk A, et al. A new perspective on tumor progression: evolution via selection for function. Evol Med Public Health. 2024;12(1):172\u20137. https:\/\/doi.org\/10.1093\/emph\/eoae021.","journal-title":"Evol Med Public Health"},{"issue":"3","key":"1322_CR13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.trecan.2025.01.001","volume":"11","author":"T Savy","year":"2025","unstructured":"Savy T, Flanders L, Karpanasamy T, Sun M, Gerlinger M. Cancer evolution: from Darwin to the extended evolutionary synthesis. Trends Cancer. 2025;11(3):204\u201315. https:\/\/doi.org\/10.1016\/j.trecan.2025.01.001.","journal-title":"Trends Cancer"},{"issue":"4","key":"1322_CR14","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.tig.2015.02.001","volume":"31","author":"A Sidow","year":"2015","unstructured":"Sidow A, Spies N. Concepts in solid tumor evolution. Trends Genet. 2015;31(4):208\u201314. https:\/\/doi.org\/10.1016\/j.tig.2015.02.001.","journal-title":"Trends Genet"},{"issue":"5","key":"1322_CR15","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/sj.bjc.6600147","volume":"86","author":"IM Lee","year":"2002","unstructured":"Lee IM, Cook NR, Manson JE, Buring JE. Randomised beta-carotene supplementation and incidence of cancer and cardiovascular disease in women: is the association modified by baseline plasma level? Br J Cancer. 2002;86(5):698\u2013701. https:\/\/doi.org\/10.1038\/sj.bjc.6600147.","journal-title":"Br J Cancer"},{"issue":"7","key":"1322_CR16","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1056\/NEJMoa055222","volume":"354","author":"J Wactawski-Wende","year":"2006","unstructured":"Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354(7):684\u201396. https:\/\/doi.org\/10.1056\/NEJMoa055222.","journal-title":"N Engl J Med"},{"issue":"21","key":"1322_CR17","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1001\/jama.297.21.2351","volume":"297","author":"BF Cole","year":"2007","unstructured":"Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007;297(21):2351\u20139. https:\/\/doi.org\/10.1001\/jama.297.21.2351.","journal-title":"JAMA"},{"issue":"12","key":"1322_CR18","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1001\/jama.2017.2115","volume":"317","author":"J Lappe","year":"2017","unstructured":"Lappe J, Watson P, Travers-Gustafson D, et al. Effect of vitamin D and calcium supplementation on cancer incidence in older women: a randomized clinical trial. JAMA. 2017;317(12):1234\u201343. https:\/\/doi.org\/10.1001\/jama.2017.2115.","journal-title":"JAMA"},{"issue":"1","key":"1322_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa1809944","volume":"380","author":"JE Manson","year":"2019","unstructured":"Manson JE, Cook NR, Lee I-M, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380(1):33\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1809944.","journal-title":"N Engl J Med"},{"issue":"1","key":"1322_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1811403","volume":"380","author":"JE Manson","year":"2019","unstructured":"Manson JE, Cook NR, Lee I-M, et al. Marine n\u22123 fatty acids and prevention of cardiovascular disease and cancer. N Engl J Med. 2019;380(1):23\u201332. https:\/\/doi.org\/10.1056\/NEJMoa1811403.","journal-title":"N Engl J Med"},{"key":"1322_CR21","doi-asserted-by":"publisher","first-page":"105522","DOI":"10.1016\/j.jsbmb.2019.105522","volume":"198","author":"JE Manson","year":"2020","unstructured":"Manson JE, Bassuk SS, Buring JE. Principal results of the VITamin D and OmegA-3 TriaL (VITAL) and updated meta-analyses of relevant vitamin D trials. J Steroid Biochem Mol Biol. 2020;198:105522. https:\/\/doi.org\/10.1016\/j.jsbmb.2019.105522.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"1322_CR22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1001\/jamaoncol.2019.4587","volume":"6","author":"M Song","year":"2019","unstructured":"Song M, Lee IM, Manson JE, et al. Effect of supplementation with marine omega-3 fatty acid on risk of colorectal adenomas and serrated polyps in the US general population: a prespecified ancillary study of a randomized clinical trial. JAMA Oncol. 2019;6(1):108\u201315. https:\/\/doi.org\/10.1001\/jamaoncol.2019.4587.","journal-title":"JAMA Oncol"},{"issue":"14","key":"1322_CR23","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1001\/jama.2011.1437","volume":"306","author":"EA Klein","year":"2011","unstructured":"Klein EA, Thompson IM, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011;306(14):1549\u201356. https:\/\/doi.org\/10.1001\/jama.2011.1437.","journal-title":"JAMA"},{"issue":"2","key":"1322_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41574-021-00593-z","volume":"18","author":"R Bouillon","year":"2022","unstructured":"Bouillon R, Manousaki D, Rosen C, Trajanoska K, Rivadeneira F, Richards JB. The health effects of vitamin D supplementation: evidence from human studies. Nat Rev Endocrinol. 2022;18(2):96\u2013110. https:\/\/doi.org\/10.1038\/s41574-021-00593-z.","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"1322_CR25","doi-asserted-by":"publisher","first-page":"824","DOI":"10.7326\/0003-4819-159-12-201312170-00729","volume":"159","author":"SP Fortmann","year":"2013","unstructured":"Fortmann SP, Burda BU, Senger CA, Lin JS, Whitlock EP. Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the U.S. preventive services task force. Ann Intern Med. 2013;159(12):824\u201334. https:\/\/doi.org\/10.7326\/0003-4819-159-12-201312170-00729.","journal-title":"Ann Intern Med"},{"issue":"8","key":"1322_CR26","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3390\/cancers16081553","volume":"16","author":"A Vishwanath","year":"2024","unstructured":"Vishwanath A, Krishna S, Manudhane AP, Hart PA, Krishna SG. Early-onset gastrointestinal malignancies: an investigation into a rising concern. Cancers. 2024;16(8):1553.","journal-title":"Cancers"},{"issue":"1","key":"1322_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13073-023-01163-w","volume":"15","author":"H Wang","year":"2023","unstructured":"Wang H, Cai Y, Jin M, et al. Identification of specific susceptibility loci for the early-onset colorectal cancer. Genome Med. 2023;15(1):13. https:\/\/doi.org\/10.1186\/s13073-023-01163-w.","journal-title":"Genome Med"},{"issue":"6","key":"1322_CR28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.annonc.2024.02.008","volume":"35","author":"RS Laskar","year":"2024","unstructured":"Laskar RS, Qu C, Huyghe JR, et al. Genome-wide association studies and Mendelian randomization analyses provide insights into the causes of early-onset colorectal cancer. Ann Oncol. 2024;35(6):523\u201336. https:\/\/doi.org\/10.1016\/j.annonc.2024.02.008.","journal-title":"Ann Oncol"},{"issue":"1","key":"1322_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/jnci\/djae208","volume":"117","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Lindstr\u00f6m S, Kraft P, Liu Y. Genetic risk, health-associated lifestyle, and risk of early-onset total cancer and breast cancer. JNCI J Natl Cancer Inst. 2024;117(1):40\u20138. https:\/\/doi.org\/10.1093\/jnci\/djae208.","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"5","key":"1322_CR30","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1053\/j.gastro.2019.12.012","volume":"158","author":"AN Archambault","year":"2020","unstructured":"Archambault AN, Su YR, Jeon J, et al. Cumulative burden of colorectal cancer-associated genetic variants is more strongly associated with early-onset vs late-onset cancer. Gastroenterology. 2020;158(5):1274-1286 e12. https:\/\/doi.org\/10.1053\/j.gastro.2019.12.012.","journal-title":"Gastroenterology"},{"issue":"3","key":"1322_CR31","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.cell.2024.12.003","volume":"188","author":"G Mauri","year":"2025","unstructured":"Mauri G, Patelli G, Crisafulli G, Siena S, Bardelli A. Tumor, \u201cage\u201d in early-onset colorectal cancer. Cell. 2025;188(3):589\u201393. https:\/\/doi.org\/10.1016\/j.cell.2024.12.003.","journal-title":"Cell"},{"issue":"1","key":"1322_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/modpathol.2014.81","volume":"28","author":"P Lochhead","year":"2015","unstructured":"Lochhead P, Chan AT, Nishihara R, et al. Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression. Mod Pathol. 2015;28(1):14\u201329.","journal-title":"Mod Pathol"},{"issue":"4","key":"1322_CR33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/path.5902","volume":"257","author":"E Gadaleta","year":"2022","unstructured":"Gadaleta E, Thorn GJ, Ross-Adams H, Jones LJ, Chelala C. Field cancerization in breast cancer. J Pathol. 2022;257(4):561\u201374. https:\/\/doi.org\/10.1002\/path.5902.","journal-title":"J Pathol"},{"issue":"3","key":"1322_CR34","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/jnci\/djab204","volume":"114","author":"P Brennan","year":"2022","unstructured":"Brennan P, Davey-Smith G. Identifying novel causes of cancers to enhance cancer prevention: new strategies are needed. J Natl Cancer Inst. 2022;114(3):353\u201360. https:\/\/doi.org\/10.1093\/jnci\/djab204.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"1322_CR35","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1136\/gutjnl-2022-327209","volume":"71","author":"K Inamura","year":"2022","unstructured":"Inamura K, Hamada T, Bullman S, Ugai T, Yachida S, Ogino S. Cancer as microenvironmental, systemic, and environmental diseases: opportunity for transdisciplinary microbiomics science. Gut. 2022;71(10):2107\u201322.","journal-title":"Gut"},{"issue":"7","key":"1322_CR36","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.cell.2024.02.009","volume":"187","author":"C Swanton","year":"2024","unstructured":"Swanton C, Bernard E, Abbosh C, et al. Embracing cancer complexity: hallmarks of systemic disease. Cell. 2024;187(7):1589\u2013616. https:\/\/doi.org\/10.1016\/j.cell.2024.02.009.","journal-title":"Cell"},{"issue":"3","key":"1322_CR37","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/gut.2010.217182","volume":"60","author":"S Ogino","year":"2011","unstructured":"Ogino S, Chan AT, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut. 2011;60(3):397\u2013411.","journal-title":"Gut"},{"issue":"4","key":"1322_CR38","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1097\/EDE.0000000000000471","volume":"27","author":"S Ogino","year":"2016","unstructured":"Ogino S, Nishihara R, VanderWeele TJ, et al. The role of molecular pathological epidemiology in the study of neoplastic and non-neoplastic diseases in the era of precision medicine. Epidemiology. 2016;27(4):602\u201311.","journal-title":"Epidemiology"},{"key":"1322_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev-pathmechdis-012418-012818","volume":"14","author":"S Ogino","year":"2019","unstructured":"Ogino S, Nowak JA, Hamada T, Milner DA Jr., Nishihara R. Insights into pathogenic interactions among environment, host, and tumor at the crossroads of molecular pathology and epidemiology. Annu Rev Pathol. 2019;14:83\u2013103. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-012418-012818.","journal-title":"Annu Rev Pathol"},{"key":"1322_CR40","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41571-020-00445-1","volume":"18","author":"N Akimoto","year":"2021","unstructured":"Akimoto N, Ugai T, Zhong R, et al. Rising incidence of early-onset colorectal cancer: a call to action. Nat Rev Clin Oncol. 2021;18:230\u201343. https:\/\/doi.org\/10.1038\/s41571-020-00445-1.","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"1322_CR41","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s10654-015-0088-4","volume":"30","author":"R Nishihara","year":"2015","unstructured":"Nishihara R, VanderWeele TJ, Shibuya K, et al. Molecular pathological epidemiology gives clues to paradoxical findings. Eur J Epidemiol. 2015;30(10):1129\u201335.","journal-title":"Eur J Epidemiol"},{"key":"1322_CR42","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.celrep.2016.03.075","volume":"15","author":"M Giannakis","year":"2016","unstructured":"Giannakis M, Mu XJ, Shukla SA, et al. Genomic correlates of immune-cell infiltrates in colorectal carcinoma. Cell Rep. 2016;15:857\u201365.","journal-title":"Cell Rep"},{"issue":"1","key":"1322_CR43","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/aje\/kws431","volume":"178","author":"R Nishihara","year":"2013","unstructured":"Nishihara R, Morikawa T, Kuchiba A, et al. A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification. Am J Epidemiol. 2013;178(1):84\u2013100.","journal-title":"Am J Epidemiol"},{"issue":"22","key":"1322_CR44","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/jnci\/92.22.1831","volume":"92","author":"ML Slattery","year":"2000","unstructured":"Slattery ML, Curtin K, Anderson K, et al. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst. 2000;92(22):1831\u20136.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"1322_CR45","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1158\/1055-9965.EPI-09-0517","volume":"18","author":"JN Poynter","year":"2009","unstructured":"Poynter JN, Haile RW, Siegmund KD, et al. Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status. Cancer Epidemiol Biomarkers Prev. 2009;18(10):2745\u201350. https:\/\/doi.org\/10.1158\/1055-9965.EPI-09-0517.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"14","key":"1322_CR46","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/jnci\/djq201","volume":"102","author":"D Limsui","year":"2010","unstructured":"Limsui D, Vierkant RA, Tillmans LS, et al. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst. 2010;102(14):1012\u201322. https:\/\/doi.org\/10.1093\/jnci\/djq201.","journal-title":"J Natl Cancer Inst"},{"key":"1322_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkab056","author":"X Wang","year":"2021","unstructured":"Wang X, Amitay E, Harrison TA, et al. Association between smoking and molecular subtypes of colorectal cancer. JNCI Cancer Spectr. 2021. https:\/\/doi.org\/10.1093\/jncics\/pkab056.","journal-title":"JNCI Cancer Spectr"},{"issue":"11","key":"1322_CR48","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1038\/s41416-020-0803-0","volume":"122","author":"EL Amitay","year":"2020","unstructured":"Amitay EL, Carr PR, Jansen L, et al. Smoking, alcohol consumption and colorectal cancer risk by molecular pathological subtypes and pathways. Br J Cancer. 2020;122(11):1604\u201310. https:\/\/doi.org\/10.1038\/s41416-020-0803-0.","journal-title":"Br J Cancer"},{"issue":"1","key":"1322_CR49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/jnci\/djy137","volume":"111","author":"T Hamada","year":"2019","unstructured":"Hamada T, Nowak JA, Masugi Y, et al. Smoking and risk of colorectal cancer sub-classified by tumor-infiltrating T cells. J Natl Cancer Inst. 2019;111(1):42\u201351. https:\/\/doi.org\/10.1093\/jnci\/djy137.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1322_CR50","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/jnci\/djab142","volume":"114","author":"T Ugai","year":"2022","unstructured":"Ugai T, Vayrynen JP, Haruki K, et al. Smoking and incidence of colorectal cancer subclassified by tumor-associated macrophage infiltrates. J Natl Cancer Inst. 2022;114(1):68\u201377. https:\/\/doi.org\/10.1093\/jnci\/djab142.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1322_CR51","doi-asserted-by":"publisher","first-page":"e000787","DOI":"10.1136\/bmjonc-2025-000787","volume":"4","author":"H Tsuyoshi","year":"2025","unstructured":"Tsuyoshi H, Tomotaka U, Carino G, et al. Smoking habit and long-term colorectal cancer incidence by exome-wide mutational and neoantigen loads: evidence based on the prospective cohort incident-tumour biobank method. BMJ Oncology. 2025;4(1):e000787. https:\/\/doi.org\/10.1136\/bmjonc-2025-000787.","journal-title":"BMJ Oncology"},{"issue":"8","key":"1322_CR52","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/aje\/kws226","volume":"176","author":"S Ogino","year":"2012","unstructured":"Ogino S, King EE, Beck AH, Sherman ME, Milner DA, Giovannucci E. Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science. Am J Epidemiol. 2012;176(8):659\u201367.","journal-title":"Am J Epidemiol"},{"issue":"7","key":"1322_CR53","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1373\/clinchem.2016.257873","volume":"62","author":"S Ogino","year":"2016","unstructured":"Ogino S, Nishihara R. All biomedical and health science researchers, including laboratory physicians and scientists, need adequate education and training in study design and statistics. Clin Chem. 2016;62(7):1039\u201340.","journal-title":"Clin Chem"},{"key":"1322_CR54","first-page":"94","volume":"10","author":"JH Lin","year":"2014","unstructured":"Lin JH, Giovannucci E. Environmental exposure and tumor heterogeneity in colorectal cancer risk and outcomes. Curr Colorectal Cancer Rep. 2014;10:94\u2013104.","journal-title":"Curr Colorectal Cancer Rep"},{"issue":"8","key":"1322_CR55","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1158\/1055-9965.EPI-15-0094","volume":"24","author":"PT Campbell","year":"2015","unstructured":"Campbell PT, Newton CC, Newcomb PA, et al. Association between body mass index and mortality for colorectal cancer survivors: overall and by tumor molecular phenotype. Cancer Epidemiol Biomarkers Prev. 2015;24(8):1229\u201338. https:\/\/doi.org\/10.1158\/1055-9965.EPI-15-0094.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1322_CR56","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.3390\/ijms16022472","volume":"16","author":"JM Ng","year":"2015","unstructured":"Ng JM, Yu J. Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer. Int J Mol Sci. 2015;16:2472\u201396. https:\/\/doi.org\/10.3390\/ijms16022472.","journal-title":"Int J Mol Sci"},{"issue":"24","key":"1322_CR57","doi-asserted-by":"publisher","first-page":"6266","DOI":"10.1158\/1078-0432.CCR-15-2765","volume":"22","author":"J Kuroiwa-Trzmielina","year":"2016","unstructured":"Kuroiwa-Trzmielina J, Wang F, Rapkins RW, et al. SNP rs16906252C>T is an expression and methylation quantitative trait locus associated with an increased risk of developing MGMT-methylated colorectal cancer. Clin Cancer Res. 2016;22(24):6266\u201377. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2765.","journal-title":"Clin Cancer Res"},{"key":"1322_CR58","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12967-016-0772-5","volume":"14","author":"J Martinez-Useros","year":"2016","unstructured":"Martinez-Useros J, Garcia-Foncillas J. Obesity and colorectal cancer: molecular features of adipose tissue. J Transl Med. 2016;14:21.","journal-title":"J Transl Med"},{"issue":"6","key":"1322_CR59","first-page":"455","volume":"13","author":"LA Hughes","year":"2017","unstructured":"Hughes LA, Simons CC, van den Brandt PA, van Engeland M, Weijenberg MP. Lifestyle, diet, and colorectal cancer risk according to (epi)genetic instability: current evidence and future direction of molecular pathological epidemiology. Curr Colorectal Cancer Rep. 2017;13(6):455\u201369.","journal-title":"Curr Colorectal Cancer Rep"},{"issue":"2","key":"1322_CR60","first-page":"163","volume":"1866","author":"M Jiang","year":"2017","unstructured":"Jiang M, Dai J, Gu D, Huang Q, Tian L. Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials. BBA Rev Cancer. 2017;1866(2):163\u201376.","journal-title":"BBA Rev Cancer"},{"issue":"1","key":"1322_CR61","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.drudis.2016.09.022","volume":"22","author":"H Patil","year":"2017","unstructured":"Patil H, Saxena SG, Barrow CJ, Kanwar JR, Kapat A, Kanwar RK. Chasing the personalized medicine dream through biomarker validation in colorectal cancer. Drug Discov Today. 2017;22(1):111\u20139. https:\/\/doi.org\/10.1016\/j.drudis.2016.09.022.","journal-title":"Drug Discov Today"},{"issue":"1","key":"1322_CR62","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3390\/molecules22010105","volume":"22","author":"T Rescigno","year":"2017","unstructured":"Rescigno T, Micolucci L, Tecce MF, Capasso A. Bioactive nutrients and nutrigenomics in age-related diseases. Molecules. 2017;22(1):105.","journal-title":"Molecules"},{"issue":"2","key":"1322_CR63","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/17460441.2017.1271321","volume":"12","author":"A Serafino","year":"2017","unstructured":"Serafino A, Sferrazza G, Colini Baldeschi A, et al. Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases. Expert Opin Drug Discov. 2017;12(2):169\u201386. https:\/\/doi.org\/10.1080\/17460441.2017.1271321.","journal-title":"Expert Opin Drug Discov"},{"issue":"8","key":"1322_CR64","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/modpathol.2017.38","volume":"30","author":"ML Slattery","year":"2017","unstructured":"Slattery ML, Lee FY, Pellatt AJ, et al. Infrequently expressed mirnas in colorectal cancer tissue and tumor molecular phenotype. Mod Pathol. 2017;30(8):1152\u201369. https:\/\/doi.org\/10.1038\/modpathol.2017.38.","journal-title":"Mod Pathol"},{"key":"1322_CR65","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.trsl.2018.01.003","volume":"196","author":"R Benelli","year":"2018","unstructured":"Benelli R, Vene R, Ferrari N. Prostaglandin-endoperoxide synthase 2 (cyclooxygenase-2), a complex target for colorectal cancer prevention and therapy. Transl Res. 2018;196:42\u201361.","journal-title":"Transl Res"},{"issue":"4","key":"1322_CR66","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/annonc\/mdy059","volume":"29","author":"PR Carr","year":"2018","unstructured":"Carr PR, Alwers E, Bienert S, et al. Lifestyle factors and risk of sporadic colorectal cancer by microsatellite instability status: a systematic review and meta-analysis. Ann Oncol. 2018;29(4):825\u201334.","journal-title":"Ann Oncol"},{"issue":"Pt 1","key":"1322_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2018.02.003","volume":"52","author":"M Rajpoot","year":"2018","unstructured":"Rajpoot M, Sharma AK, Sharma A, Gupta GK. Understanding the microbiome: emerging biomarkers for exploiting the microbiota for personalized medicine against cancer. Semin Cancer Biol. 2018;52(Pt 1):1\u20138. https:\/\/doi.org\/10.1016\/j.semcancer.2018.02.003.","journal-title":"Semin Cancer Biol"},{"key":"1322_CR68","doi-asserted-by":"publisher","DOI":"10.26402\/jpp.2018.3.02","author":"M Waluga","year":"2018","unstructured":"Waluga M, Zorniak M, Fichna J, Kukla M, Hartleb M. Pharmacological and dietary factors in prevention of colorectal cancer. J Physiol Pharmacol. 2018. https:\/\/doi.org\/10.26402\/jpp.2018.3.02.","journal-title":"J Physiol Pharmacol"},{"key":"1322_CR69","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/cancers10100349","volume":"10","author":"S Zakhari","year":"2018","unstructured":"Zakhari S, Hoek JB. Epidemiology of moderate alcohol consumption and breast cancer: association or causation? Cancers. 2018;10:349.","journal-title":"Cancers"},{"issue":"9","key":"1322_CR70","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.7150\/jca.24048","volume":"9","author":"S Zhang","year":"2018","unstructured":"Zhang S, Cai S, Ma Y. Association between Fusobacterium nucleatum and colorectal cancer: progress and future directions. J Cancer. 2018;9(9):1652\u20139. https:\/\/doi.org\/10.7150\/jca.24048.","journal-title":"J Cancer"},{"issue":"4","key":"1322_CR71","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.drudis.2019.02.009","volume":"24","author":"B Chen","year":"2019","unstructured":"Chen B, Du G, Guo J, Zhang Y. Bugs, drugs, and cancer: can the microbiome be a potential therapeutic target for cancer management? Drug Discov Today. 2019;24(4):1000\u20139.","journal-title":"Drug Discov Today"},{"issue":"4","key":"1322_CR72","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/annonc\/mdz044","volume":"30","author":"MJ Gunter","year":"2019","unstructured":"Gunter MJ, Alhomoud S, Arnold M, et al. Meeting report from the joint IARC-NCI international cancer seminar series: a focus on colorectal cancer. Ann Oncol. 2019;30(4):510\u20139. https:\/\/doi.org\/10.1093\/annonc\/mdz044.","journal-title":"Ann Oncol"},{"key":"1322_CR73","doi-asserted-by":"publisher","first-page":"109142","DOI":"10.1016\/j.biopha.2019.109142","volume":"117","author":"XM Huang","year":"2019","unstructured":"Huang XM, Yang ZJ, Xie Q, Zhang ZK, Zhang H, Ma JY. Natural products for treating colorectal cancer: a mechanistic review. Biomed Pharmacother. 2019;117:109142. https:\/\/doi.org\/10.1016\/j.biopha.2019.109142.","journal-title":"Biomed Pharmacother"},{"key":"1322_CR74","doi-asserted-by":"publisher","first-page":"108988","DOI":"10.1016\/j.biopha.2019.108988","volume":"116","author":"K Luo","year":"2019","unstructured":"Luo K, Zhang Y, Xv C, et al. Fusobacterium nucleatum, the communication with colorectal cancer. Biomed Pharmacother. 2019;116:108988. https:\/\/doi.org\/10.1016\/j.biopha.2019.108988.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1322_CR75","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ijc.32104","volume":"145","author":"R Myte","year":"2019","unstructured":"Myte R, Gylling B, Haggstrom J, et al. Metabolic factors and the risk of colorectal cancer by KRAS and BRAF mutation status. Int J Cancer. 2019;145(2):327\u201337. https:\/\/doi.org\/10.1002\/ijc.32104.","journal-title":"Int J Cancer"},{"issue":"17","key":"1322_CR76","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.2174\/0929867326666190620110732","volume":"27","author":"A Nappi","year":"2019","unstructured":"Nappi A, Nasti G, Romano C, Berretta M, Ottaiano A. Metastatic colorectal cancer: prognostic and predictive factors. Curr Med Chem. 2019;27(17):2779\u201391. https:\/\/doi.org\/10.2174\/0929867326666190620110732.","journal-title":"Curr Med Chem"},{"issue":"1","key":"1322_CR77","doi-asserted-by":"publisher","first-page":"78","DOI":"10.5334\/aogh.2873","volume":"86","author":"A Jatho","year":"2020","unstructured":"Jatho A, Tran BT, Cambia JM, Nanyingi M, Mugisha NM. Cancer risk studies and priority areas for cancer risk appraisal in Uganda. Ann Glob Health. 2020;86(1):78. https:\/\/doi.org\/10.5334\/aogh.2873.","journal-title":"Ann Glob Health"},{"key":"1322_CR78","doi-asserted-by":"publisher","DOI":"10.14670\/HH-18-236","author":"L Losi","year":"2020","unstructured":"Losi L, Zanocco-Marani T, Grande A. Cadherins down-regulation: towards a better understanding of their relevance in colorectal cancer. Histol Histopathol. 2020. https:\/\/doi.org\/10.14670\/HH-18-236.","journal-title":"Histol Histopathol"},{"issue":"6","key":"1322_CR79","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3748\/wjg.v26.i6.562","volume":"26","author":"ST Wang","year":"2020","unstructured":"Wang ST, Cui WQ, Pan D, Jiang M, Chang B, Sang LX. Tea polyphenols and their chemopreventive and therapeutic effects on colorectal cancer. World J Gastroenterol. 2020;26(6):562\u201397. https:\/\/doi.org\/10.3748\/wjg.v26.i6.562.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1322_CR80","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.clcc.2020.09.007","volume":"20","author":"SM Advani","year":"2021","unstructured":"Advani SM, Swartz MD, Loree J, et al. Epidemiology and molecular-pathologic characteristics of CpG Island Methylator Phenotype (CIMP) in colorectal cancer. Clin Colorectal Cancer. 2021;20(2):137-47.e1. https:\/\/doi.org\/10.1016\/j.clcc.2020.09.007.","journal-title":"Clin Colorectal Cancer"},{"key":"1322_CR81","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23810","author":"J Bai","year":"2021","unstructured":"Bai J, Chen H, Bai X. Relationship between microsatellite status and immune microenvironment of colorectal cancer and its application to diagnosis and treatment. J Clin Lab Anal. 2021. https:\/\/doi.org\/10.1002\/jcla.23810.","journal-title":"J Clin Lab Anal"},{"key":"1322_CR82","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.semcancer.2020.06.006","volume":"70","author":"K Inamura","year":"2021","unstructured":"Inamura K. Gut microbiota contributes towards immunomodulation against cancer: new frontiers in precision cancer therapeutics. Semin Cancer Biol. 2021;70:11\u201323. https:\/\/doi.org\/10.1016\/j.semcancer.2020.06.006.","journal-title":"Semin Cancer Biol"},{"issue":"22","key":"1322_CR83","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.3748\/wjg.v27.i22.2963","volume":"27","author":"Y Sun","year":"2021","unstructured":"Sun Y, Zhang Z, Zheng CQ, Sang LX. Mucosal lesions of the upper gastrointestinal tract in patients with ulcerative colitis: a review. World J Gastroenterol. 2021;27(22):2963\u201378. https:\/\/doi.org\/10.3748\/wjg.v27.i22.2963.","journal-title":"World J Gastroenterol"},{"key":"1322_CR84","doi-asserted-by":"publisher","first-page":"108360","DOI":"10.1016\/j.mrrev.2020.108360","volume":"787","author":"R Wang","year":"2021","unstructured":"Wang R, Chen M, Ye X, Poon K. Role and potential clinical utility of ARID1A in gastrointestinal malignancy. Mutat Res\/Rev Mutat Res. 2021;787:108360.","journal-title":"Mutat Res\/Rev Mutat Res"},{"issue":"2","key":"1322_CR85","doi-asserted-by":"publisher","first-page":"147","DOI":"10.20892\/j.issn.2095-3941.2020.0651","volume":"19","author":"S Li","year":"2022","unstructured":"Li S, Liu J, Zheng X, et al. Tumorigenic bacteria in colorectal cancer: mechanisms and treatments. Cancer Biol Med. 2022;19(2):147\u201362. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2020.0651.","journal-title":"Cancer Biol Med"},{"key":"1322_CR86","doi-asserted-by":"publisher","first-page":"852194","DOI":"10.3389\/fonc.2022.852194","volume":"12","author":"Y Lin","year":"2022","unstructured":"Lin Y, Kong DX, Zhang YN. Does the microbiota composition influence the efficacy of colorectal cancer immunotherapy? Front Oncol. 2022;12:852194. https:\/\/doi.org\/10.3389\/fonc.2022.852194.","journal-title":"Front Oncol"},{"issue":"4","key":"1322_CR87","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s11684-023-1015-9","volume":"17","author":"Z Jin","year":"2023","unstructured":"Jin Z, Zhou Q, Cheng J-N, Jia Q, Zhu B. Heterogeneity of the tumor immune microenvironment and clinical interventions. Front Med. 2023;17(4):617\u201348. https:\/\/doi.org\/10.1007\/s11684-023-1015-9.","journal-title":"Front Med"},{"issue":"6","key":"1322_CR88","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41416-022-02112-x","volume":"128","author":"K Kosumi","year":"2023","unstructured":"Kosumi K, Baba Y, Yamamura K, et al. Intratumour Fusobacterium nucleatum and immune response to oesophageal cancer. Br J Cancer. 2023;128(6):1155\u201365. https:\/\/doi.org\/10.1038\/s41416-022-02112-x.","journal-title":"Br J Cancer"},{"issue":"2","key":"1322_CR89","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.gande.2025.01.002","volume":"3","author":"N Agrawal","year":"2025","unstructured":"Agrawal N, Lanjhiyana SK, Jaiswal M, Siddiqui MA, Gupta S. Colorectal cancer spectrum: from subtypes and epidemiology to oncotherapies. Gastroenterol Endosc. 2025;3(2):55\u201364. https:\/\/doi.org\/10.1016\/j.gande.2025.01.002.","journal-title":"Gastroenterol Endosc"},{"key":"1322_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/0109298673290777240301071513","volume":"31","author":"Z Peng","year":"2024","unstructured":"Peng Z, Ding Y, Zhang P, et al. Artificial intelligence application for anti-tumor drug synergy prediction. Curr Med Chem. 2024;31:1\u201314. https:\/\/doi.org\/10.2174\/0109298673290777240301071513.","journal-title":"Curr Med Chem"},{"key":"1322_CR91","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2024.2404238","author":"N Teixeira","year":"2025","unstructured":"Teixeira N, Bai\u00e3o A, Dias S, Sarmento B. The progress and challenges in modeling colorectal cancer and the impact on novel drug discovery. Expert Opin Drug Discov. 2025. https:\/\/doi.org\/10.1080\/17460441.2024.2404238.","journal-title":"Expert Opin Drug Discov"},{"issue":"15","key":"1322_CR92","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1158\/1078-0432.Ccr-22-3468","volume":"30","author":"L Espelage","year":"2024","unstructured":"Espelage L, Wagner N, Placke J-M, Ugurel S, Tasdogan A. The interplay between metabolic adaptations and diet in cancer immunotherapy. Clin Cancer Res. 2024;30(15):3117\u201327. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-22-3468.","journal-title":"Clin Cancer Res"},{"key":"1322_CR93","doi-asserted-by":"publisher","first-page":"101293","DOI":"10.1016\/j.lanepe.2025.101293","volume":"53","author":"T Ugai","year":"2025","unstructured":"Ugai T, van Guelpen B, Mucci LA, Ogino S. Enhancing existing tumour biobanks in European prospective cohort studies. Lancet Reg Health Eur. 2025;53:101293. https:\/\/doi.org\/10.1016\/j.lanepe.2025.101293.","journal-title":"Lancet Reg Health Eur"},{"key":"1322_CR94","doi-asserted-by":"publisher","unstructured":"Ogino S, Patel A, Ugai S, Giannakis M, Ugai T. Unique role of the prospective cohort incident-tumor biobank method in etiological research. Lancet Reg Health Am. 2025 (in press). https:\/\/doi.org\/10.1016\/j.lana.2025.101290.","DOI":"10.1016\/j.lana.2025.101290"},{"issue":"1","key":"1322_CR95","doi-asserted-by":"publisher","first-page":"2452237","DOI":"10.1080\/19490976.2025.2452237","volume":"17","author":"S Ugai","year":"2025","unstructured":"Ugai S, Liu L, Kosumi K, et al. Long-term yogurt intake and colorectal cancer incidence subclassified by Bifidobacterium abundance in tumor. Gut Microbes. 2025;17(1):2452237. https:\/\/doi.org\/10.1080\/19490976.2025.2452237.","journal-title":"Gut Microbes"},{"issue":"21","key":"1322_CR96","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1056\/NEJMoa067208","volume":"356","author":"AT Chan","year":"2007","unstructured":"Chan AT, Ogino S, Fuchs CS. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med. 2007;356(21):2131\u201342.","journal-title":"N Engl J Med"},{"issue":"1","key":"1322_CR97","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/ijc.32083","volume":"145","author":"KKF Tsoi","year":"2019","unstructured":"Tsoi KKF, Ho JMW, Chan FCH, Sung JJY. Long-term use of low-dose aspirin for cancer prevention: a 10-year population cohort study in Hong Kong. Int J Cancer. 2019;145(1):267\u201373. https:\/\/doi.org\/10.1002\/ijc.32083.","journal-title":"Int J Cancer"},{"issue":"5","key":"1322_CR98","doi-asserted-by":"publisher","first-page":"djy170","DOI":"10.1093\/jnci\/djy170","volume":"111","author":"EL Amitay","year":"2019","unstructured":"Amitay EL, Carr PR, Jansen L, et al. Association of aspirin and nonsteroidal anti-inflammatory drugs with colorectal cancer risk by molecular subtypes. J Natl Cancer Inst. 2019;111(5):djy170. https:\/\/doi.org\/10.1093\/jnci\/djy170.","journal-title":"J Natl Cancer Inst"},{"key":"1322_CR99","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11888-016-0306-9","volume":"12","author":"C Coyle","year":"2016","unstructured":"Coyle C, Cafferty FH, Langley RE. Aspirin and colorectal cancer prevention and treatment: is it for everyone? Curr Colorectal Cancer Rep. 2016;12:27\u201334. https:\/\/doi.org\/10.1007\/s11888-016-0306-9.","journal-title":"Curr Colorectal Cancer Rep"},{"issue":"4","key":"1322_CR100","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1177\/1078155220984846","volume":"27","author":"YM Belayneh","year":"2021","unstructured":"Belayneh YM, Amare GG, Meharie BG. Updates on the molecular mechanisms of aspirin in the prevention of colorectal cancer: review. J Oncol Pharm Pract. 2021;27(4):954\u201361. https:\/\/doi.org\/10.1177\/1078155220984846.","journal-title":"J Oncol Pharm Pract"},{"issue":"9","key":"1322_CR101","doi-asserted-by":"publisher","first-page":"e70005","DOI":"10.7759\/cureus.70005","volume":"16","author":"CI Miret Durazo","year":"2024","unstructured":"Miret Durazo CI, Zachariah Saji S, Rawat A, et al. Exploring Aspirin\u2019s potential in cancer prevention: a comprehensive review of the current evidence. Cureus. 2024;16(9):e70005. https:\/\/doi.org\/10.7759\/cureus.70005.","journal-title":"Cureus"},{"key":"1322_CR102","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev-pharmtox-052020-023107","volume":"63","author":"DG Menter","year":"2023","unstructured":"Menter DG, Bresalier RS. An aspirin a day: new pharmacological developments and cancer chemoprevention. Annu Rev Pharmacol Toxicol. 2023;63:165\u201386. https:\/\/doi.org\/10.1146\/annurev-pharmtox-052020-023107.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"1322_CR103","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.amepre.2014.09.031","volume":"48","author":"A Nishi","year":"2015","unstructured":"Nishi A, Kawachi I, Koenen KC, Wu K, Nishihara R, Ogino S. Lifecourse epidemiology and molecular pathological epidemiology. Am J Prev Med. 2015;48(1):116\u20139.","journal-title":"Am J Prev Med"},{"key":"1322_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092016","author":"N Akimoto","year":"2021","unstructured":"Akimoto N, Zhao M, Ugai T, et al. Tumor long interspersed nucleotide element-1 (LINE-1) hypomethylation in relation to age of colorectal cancer diagnosis and prognosis. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13092016.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1322_CR105","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ccell.2024.02.009","volume":"42","author":"A Rosendahl Huber","year":"2024","unstructured":"Rosendahl Huber A, Pleguezuelos-Manzano C, Puschhof J, et al. Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer. Cancer Cell. 2024;42(3):487-496.e6. https:\/\/doi.org\/10.1016\/j.ccell.2024.02.009.","journal-title":"Cancer Cell"},{"issue":"4","key":"1322_CR106","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1158\/2159-8290.Cd-23-1494","volume":"14","author":"HY Lee","year":"2024","unstructured":"Lee HY, Song M, Stopsack KH, et al. The cancer spectrum theory. Cancer Discov. 2024;14(4):589\u201393. https:\/\/doi.org\/10.1158\/2159-8290.Cd-23-1494.","journal-title":"Cancer Discov"},{"issue":"9","key":"1322_CR107","doi-asserted-by":"publisher","first-page":"101737","DOI":"10.1016\/j.xcrm.2024.101737","volume":"5","author":"G Mauri","year":"2024","unstructured":"Mauri G, Patelli G, Sartore-Bianchi A, et al. Early-onset cancers: biological bases and clinical implications. Cell Rep Med. 2024;5(9):101737. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101737.","journal-title":"Cell Rep Med"},{"issue":"1","key":"1322_CR108","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41698-023-00414-8","volume":"7","author":"C Lu","year":"2023","unstructured":"Lu C, Zhang X, Schardey J, et al. Molecular characteristics of microsatellite stable early-onset colorectal cancer as predictors of prognosis and immunotherapeutic response. NPJ Precis Oncol. 2023;7(1):63. https:\/\/doi.org\/10.1038\/s41698-023-00414-8.","journal-title":"NPJ Precis Oncol"},{"key":"1322_CR109","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-024-07747-9","volume":"633","author":"AJ Cornish","year":"2024","unstructured":"Cornish AJ, Gruber AJ, Kinnersley B, et al. The genomic landscape of 2023 colorectal cancers. Nature. 2024;633:127\u201336. https:\/\/doi.org\/10.1038\/s41586-024-07747-9.","journal-title":"Nature"},{"key":"1322_CR110","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1476-4598-9-125","volume":"9","author":"Y Baba","year":"2010","unstructured":"Baba Y, Huttenhower C, Nosho K, et al. Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors. Mol Cancer. 2010;9:125.","journal-title":"Mol Cancer"},{"issue":"9","key":"1322_CR111","doi-asserted-by":"publisher","first-page":"e45357","DOI":"10.1371\/journal.pone.0045357","volume":"7","author":"M Antelo","year":"2012","unstructured":"Antelo M, Balaguer F, Shia J, et al. A high degree of LINE-1 hypomethylation is a unique feature of early-onset colorectal cancer. PLoS ONE. 2012;7(9):e45357. https:\/\/doi.org\/10.1371\/journal.pone.0045357.","journal-title":"PLoS ONE"},{"issue":"3","key":"1322_CR112","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1093\/nar\/gnh032","volume":"32","author":"AS Yang","year":"2004","unstructured":"Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res. 2004;32(3):e38.","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"1322_CR113","doi-asserted-by":"publisher","first-page":"6823","DOI":"10.1093\/nar\/gki987","volume":"33","author":"DJ Weisenberger","year":"2005","unstructured":"Weisenberger DJ, Campan M, Long TI, et al. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res. 2005;33(21):6823\u201336.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1322_CR114","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13148-025-01817-z","volume":"17","author":"JS Li","year":"2025","unstructured":"Li JS, Riggins K, Yang L, et al. DNA methylation profiling at base-pair resolution reveals unique epigenetic features of early-onset colorectal cancer in underrepresented populations. Clin Epigenetics. 2025;17(1):11. https:\/\/doi.org\/10.1186\/s13148-025-01817-z.","journal-title":"Clin Epigenetics"},{"issue":"3","key":"1322_CR115","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/sj.onc.1210631","volume":"27","author":"G Howard","year":"2008","unstructured":"Howard G, Eiges R, Gaudet F, Jaenisch R, Eden A. Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice. Oncogene. 2008;27(3):404\u20138. https:\/\/doi.org\/10.1038\/sj.onc.1210631.","journal-title":"Oncogene"},{"issue":"1","key":"1322_CR116","doi-asserted-by":"publisher","first-page":"6874","DOI":"10.1038\/s41598-023-33932-3","volume":"13","author":"N Besselink","year":"2023","unstructured":"Besselink N, Keijer J, Vermeulen C, et al. The genome-wide mutational consequences of DNA hypomethylation. Sci Rep. 2023;13(1):6874. https:\/\/doi.org\/10.1038\/s41598-023-33932-3.","journal-title":"Sci Rep"},{"issue":"6","key":"1322_CR117","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1136\/gut.2009.183707","volume":"59","author":"ES Schernhammer","year":"2010","unstructured":"Schernhammer ES, Giovannucci E, Kawasaki T, Rosner B, Fuchs CS, Ogino S. Dietary folate, alcohol, and B vitamins in relation to LINE-1 hypomethylation in colon cancer. Gut. 2010;59(6):794\u20139.","journal-title":"Gut"},{"issue":"7","key":"1322_CR118","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1136\/gutjnl-2022-327608","volume":"72","author":"J Roelands","year":"2023","unstructured":"Roelands J, van der Ploeg M, Ijsselsteijn ME, et al. Transcriptomic and immunophenotypic profiling reveals molecular and immunological hallmarks of colorectal cancer tumourigenesis. Gut. 2023;72(7):1326\u201339. https:\/\/doi.org\/10.1136\/gutjnl-2022-327608.","journal-title":"Gut"},{"key":"1322_CR119","doi-asserted-by":"publisher","first-page":"101756","DOI":"10.1016\/j.smim.2023.101756","volume":"67","author":"R Newsome","year":"2023","unstructured":"Newsome R, Yang Y, Jobin C. Western diet influences on microbiome and carcinogenesis. Semin Immunol. 2023;67:101756. https:\/\/doi.org\/10.1016\/j.smim.2023.101756.","journal-title":"Semin Immunol"},{"issue":"2","key":"1322_CR120","doi-asserted-by":"publisher","first-page":"189281","DOI":"10.1016\/j.bbcan.2025.189281","volume":"1880","author":"F Ghorbaninezhad","year":"2025","unstructured":"Ghorbaninezhad F, Nour MA, Farzam OR, et al. The tumor microenvironment and dendritic cells: developers of pioneering strategies in colorectal cancer immunotherapy? Biochimica et Biophysica Acta (BBA) Rev Cancer. 2025;1880(2):189281. https:\/\/doi.org\/10.1016\/j.bbcan.2025.189281.","journal-title":"Biochimica et Biophysica Acta (BBA) Rev Cancer"},{"issue":"2","key":"1322_CR121","doi-asserted-by":"publisher","first-page":"e1012707","DOI":"10.1371\/journal.pcbi.1012707","volume":"21","author":"MC Lau","year":"2025","unstructured":"Lau MC, Borowsky J, V\u00e4yrynen JP, et al. Tumor-immune partitioning and clustering algorithm for identifying tumor-immune cell spatial interaction signatures within the tumor microenvironment. PLoS Comput Biol. 2025;21(2):e1012707. https:\/\/doi.org\/10.1371\/journal.pcbi.1012707.","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"1322_CR122","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/path.2774","volume":"222","author":"K Nosho","year":"2010","unstructured":"Nosho K, Baba Y, Tanaka N, et al. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer and prognosis: cohort study and literature review. J Pathol. 2010;222(4):350\u201366.","journal-title":"J Pathol"},{"issue":"4","key":"1322_CR123","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00262-021-03056-6","volume":"71","author":"T Ugai","year":"2022","unstructured":"Ugai T, V\u00e4yrynen JP, Lau MC, et al. Immune cell profiles in the tumor microenvironment of early-onset, intermediate-onset, and later-onset colorectal cancer. Cancer Immunol Immunother. 2022;71(4):933\u201342. https:\/\/doi.org\/10.1007\/s00262-021-03056-6.","journal-title":"Cancer Immunol Immunother"},{"issue":"10","key":"1322_CR124","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/jnci\/djae143","volume":"116","author":"Y-Y Tsai","year":"2024","unstructured":"Tsai Y-Y, Nair KG, Barot SV, et al. Differences in tumor-associated T-cell receptor repertoires between early-onset and average-onset colorectal cancer. JNCI J Natl Cancer Inst. 2024;116(10):1645\u201353. https:\/\/doi.org\/10.1093\/jnci\/djae143.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"1322_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.100974","author":"M Du","year":"2023","unstructured":"Du M, Gu D, Xin J, et al. Integrated multi-omics approach to distinct molecular characterization and classification of early-onset colorectal cancer. Cell Rep Med. 2023. https:\/\/doi.org\/10.1016\/j.xcrm.2023.100974.","journal-title":"Cell Rep Med"},{"issue":"6","key":"1322_CR126","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1053\/j.gastro.2017.08.045","volume":"153","author":"L Liu","year":"2017","unstructured":"Liu L, Nishihara R, Qian ZR, et al. Association between inflammatory diet pattern and risk of colorectal carcinoma subtypes classified by immune responses to tumor. Gastroenterology. 2017;153(6):1517-1530.e14. https:\/\/doi.org\/10.1053\/j.gastro.2017.08.045.","journal-title":"Gastroenterology"},{"issue":"5","key":"1322_CR127","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1053\/j.gastro.2016.07.030","volume":"151","author":"Y Cao","year":"2016","unstructured":"Cao Y, Nishihara R, Qian ZR, et al. Regular aspirin use associates with lower risk of colorectal cancers with low numbers of tumor-infiltrating lymphocytes. Gastroenterology. 2016;151(5):879\u201392.","journal-title":"Gastroenterology"},{"issue":"3","key":"1322_CR128","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1158\/2159-8290.Cd-22-1038","volume":"13","author":"I Ben-Aharon","year":"2023","unstructured":"Ben-Aharon I, van Laarhoven HWM, Fontana E, Obermannova R, Nilsson M, Lordick F. Early-onset cancer in the gastrointestinal tract is on the rise\u2014evidence and implications. Cancer Discov. 2023;13(3):538\u201351. https:\/\/doi.org\/10.1158\/2159-8290.Cd-22-1038.","journal-title":"Cancer Discov"},{"issue":"8","key":"1322_CR129","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.tim.2024.01.007","volume":"32","author":"YQ Lu","year":"2024","unstructured":"Lu YQ, Qiao H, Tan XR, Liu N. Broadening oncological boundaries: the intratumoral microbiota. Trends Microbiol. 2024;32(8):807\u201322. https:\/\/doi.org\/10.1016\/j.tim.2024.01.007.","journal-title":"Trends Microbiol"},{"issue":"2","key":"1322_CR130","doi-asserted-by":"publisher","first-page":"2269623","DOI":"10.1080\/19490976.2023.2269623","volume":"15","author":"K Mima","year":"2023","unstructured":"Mima K, Hamada T, Inamura K, Baba H, Ugai T, Ogino S. The microbiome and rise of early-onset cancers: knowledge gaps and research opportunities. Gut Microbes. 2023;15(2):2269623. https:\/\/doi.org\/10.1080\/19490976.2023.2269623.","journal-title":"Gut Microbes"},{"key":"1322_CR131","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41586-024-07182-w","volume":"628","author":"M Zepeda-Rivera","year":"2024","unstructured":"Zepeda-Rivera M, Minot SS, Bouzek H, et al. A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche. Nature. 2024;628:424\u201332. https:\/\/doi.org\/10.1038\/s41586-024-07182-w.","journal-title":"Nature"},{"issue":"1","key":"1322_CR132","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s44321-024-00177-0","volume":"17","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, Kleis L, Depetris-Chauvin A, et al. Beneficial microbiome and diet interplay in early-onset colorectal cancer. EMBO Mol Med. 2025;17(1):9\u201330. https:\/\/doi.org\/10.1038\/s44321-024-00177-0.","journal-title":"EMBO Mol Med"},{"key":"1322_CR133","doi-asserted-by":"publisher","DOI":"10.1101\/2023.03.10.23287127","author":"P Georgeson","year":"2024","unstructured":"Georgeson P, Steinfelder RS, Harrison TA, et al. Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival. medRxiv. 2024. https:\/\/doi.org\/10.1101\/2023.03.10.23287127.","journal-title":"medRxiv."},{"key":"1322_CR134","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09025-8","author":"M D\u00edaz-Gay","year":"2025","unstructured":"D\u00edaz-Gay M, dos Santos W, Moody S, et al. Geographic and age variations in mutational processes in colorectal cancer. Nature. 2025. https:\/\/doi.org\/10.1038\/s41586-025-09025-8.","journal-title":"Nature"},{"issue":"7802","key":"1322_CR135","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41586-020-2080-8","volume":"580","author":"C Pleguezuelos-Manzano","year":"2020","unstructured":"Pleguezuelos-Manzano C, Puschhof J, Rosendahl Huber A, et al. Mutational signature in colorectal cancer caused by genotoxic pks(+) E. coli. Nature. 2020;580(7802):269\u201373. https:\/\/doi.org\/10.1038\/s41586-020-2080-8.","journal-title":"Nature"},{"issue":"4","key":"1322_CR136","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1053\/j.gastro.2022.06.054","volume":"163","author":"K Arima","year":"2022","unstructured":"Arima K, Zhong R, Ugai T, et al. Western-style diet, pks island-carrying Escherichia coli, and colorectal cancer: analyses from two large prospective cohort studies. Gastroenterology. 2022;163(4):862\u201374. https:\/\/doi.org\/10.1053\/j.gastro.2022.06.054.","journal-title":"Gastroenterology"},{"issue":"1","key":"1322_CR137","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jamaoncol.2018.4280","volume":"5","author":"PH Liu","year":"2019","unstructured":"Liu PH, Wu K, Ng K, et al. Association of obesity with risk of early-onset colorectal cancer among women. JAMA Oncol. 2019;5(1):37\u201344. https:\/\/doi.org\/10.1001\/jamaoncol.2018.4280.","journal-title":"JAMA Oncol"},{"issue":"2","key":"1322_CR138","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.gastha.2021.10.009","volume":"1","author":"Z Li","year":"2022","unstructured":"Li Z, Chen H, Fritz CDL, et al. Type 2 diabetes and risk of early-onset colorectal cancer. Gastro Hep Adv. 2022;1(2):186\u201393. https:\/\/doi.org\/10.1016\/j.gastha.2021.10.009.","journal-title":"Gastro Hep Adv"},{"issue":"4","key":"1322_CR139","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1053\/j.gastro.2021.12.239","volume":"162","author":"H Li","year":"2022","unstructured":"Li H, Boakye D, Chen X, et al. Associations of body mass index at different ages with early-onset colorectal cancer. Gastroenterology. 2022;162(4):1088-1097.e3. https:\/\/doi.org\/10.1053\/j.gastro.2021.12.239.","journal-title":"Gastroenterology"},{"key":"1322_CR140","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000006315","author":"H Kawamura","year":"2025","unstructured":"Kawamura H, Ugai T, Takashima Y, et al. Appendectomy and long-term colorectal cancer incidence, overall and by tumor Fusobacterium nucleatum status. Ann Surg. 2025. https:\/\/doi.org\/10.1097\/sla.0000000000006315.","journal-title":"Ann Surg"},{"issue":"11","key":"1322_CR141","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s10552-024-01901-4","volume":"35","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Khil J, Feng X, Ugai T, Ogino S, Giovannucci E. Risk of colorectal cancer and adenoma after an appendectomy: results from three large prospective cohort studies and meta-analysis. Cancer Causes Control. 2024;35(11):1457\u201366. https:\/\/doi.org\/10.1007\/s10552-024-01901-4.","journal-title":"Cancer Causes Control"},{"issue":"7","key":"1322_CR142","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.cgh.2023.08.023","volume":"22","author":"C Yuan","year":"2024","unstructured":"Yuan C, Wang QL, Kim H, et al. Being breastfed in infancy and risk of colorectal cancer and precursor lesions. Clin Gastroenterol Hepatol. 2024;22(7):1508-1517.e11. https:\/\/doi.org\/10.1016\/j.cgh.2023.08.023.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"1322_CR143","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2105\/AJPH.2016.303338","volume":"106","author":"Y Bao","year":"2016","unstructured":"Bao Y, Bertoia ML, Lenart EB, et al. Origin, methods, and evolution of the three nurses\u2019 health studies. Am J Public Health. 2016;106(9):1573\u201381. https:\/\/doi.org\/10.2105\/AJPH.2016.303338.","journal-title":"Am J Public Health"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-025-01322-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10654-025-01322-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-025-01322-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T05:52:46Z","timestamp":1767160366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10654-025-01322-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":143,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1322"],"URL":"https:\/\/doi.org\/10.1007\/s10654-025-01322-w","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have not disclosed any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"The authors have no relevant financial or non-financial interests to disclose. The authors do not have any affiliations, memberships, funding, or financial holdings that might be perceived as affecting the objectivity of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure statement"}},{"value":"We use HUGO (Human Genome Organisation)-approved official symbols for genes and gene products, such as PTGS2; all of which are described at\n                      \n                      . The official symbols of genes are italicized, while those for gene products are non-italicized.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Use of standardized official symbols"}}]}}